» Articles » PMID: 20550678

Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats: the Forgotten Right Ventricle

Abstract

Background: In patients with myocardial infarction or heart failure, right ventricular (RV) dysfunction is associated with death, shock and arrhythmias. In patients with type 2 diabetes mellitus, structural and functional alterations of the left ventricle (LV) are highly prevalent, however, little is known about the impact of diabetes on RV characteristics. The purpose of the present study was to investigate whether LV changes are paralleled by RV alterations in a rat model of diabetes.

Methods: Zucker diabetic fatty (ZDF) and control (ZL) rats underwent echocardiography and positron emission tomography (PET) scanning using [18F]-2-fluoro-2-deoxy-D-glucose under hyperinsulinaemic euglycaemic clamp conditions. Glucose, insulin, triglycerides and fatty acids were assessed from trunk blood. Another group of rats received an insulin or saline injection to study RV insulin signaling.

Results: ZDF rats developed hyperglycaemia, hyperinsulinaemia and dyslipidaemia (all p < 0.05). Echocardiography revealed depressed LV fractional shortening and tricuspid annular plane systolic excursion (TAPSE) in ZDF vs. ZL rats (both p < 0.05). A decrease in LV and RV insulin-mediated glucose utilisation was found in ZDF vs. ZL rats (both p < 0.05). LV associated with RV with respect to systolic function (r = 0.86, p < 0.05) and glucose utilisation (r = 0.74, p < 0.05). TAPSE associated with RV MRglu (r = 0.92, p < 0.05) and M-value (r = 0.91, p < 0.0001) and RV MRglu associated with M-value (r = 0.77, p < 0.05). Finally, reduced RV insulin-stimulated phosphorylation of Akt was found in ZDF vs. ZL (p < 0.05).

Conclusions: LV changes were paralleled by RV alterations in insulin-stimulated glucose utilisation and RV systolic function in a rat model of diabetes, which may be attributed to ventricular interdependence as well as to the uniform effect of diabetes. Since diabetic patients are prone to develop diabetic cardiomyopathy and myocardial ischaemia, it might be suggested that RV dysfunction plays a central role in cardiac abnormalities in this population.

Citing Articles

Impact of diabetes mellitus on right ventricular dysfunction and ventricular interdependence in hypertensive patients with heart failure with reduced ejection fraction assessed via 3.0 T cardiac MRI.

Zhang G, Shi R, Li X, Yan W, Xu H, Li Y Cardiovasc Diabetol. 2024; 23(1):375.

PMID: 39443983 PMC: 11515597. DOI: 10.1186/s12933-024-02472-z.


Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target.

Dattani A, Singh A, McCann G, Gulsin G J Cardiovasc Dev Dis. 2024; 11(1).

PMID: 38248882 PMC: 10817027. DOI: 10.3390/jcdd11010012.


Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery.

Gao S, Liu X, Li T, Chen L, Feng Y, Wang Y Acta Pharmacol Sin. 2023; 45(1):23-35.

PMID: 37644131 PMC: 10770177. DOI: 10.1038/s41401-023-01152-0.


Age and Sex Differences in Heart Failure With Preserved Ejection Fraction.

Kobak K, Zarzycka W, Chiao Y Front Aging. 2022; 3:811436.

PMID: 35821846 PMC: 9261310. DOI: 10.3389/fragi.2022.811436.


Heart failure in diabetes.

Jankauskas S, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A Metabolism. 2021; 125:154910.

PMID: 34627874 PMC: 8941799. DOI: 10.1016/j.metabol.2021.154910.


References
1.
Kosmala W, Colonna P, Przewlocka-Kosmala M, Mazurek W . Right ventricular dysfunction in asymptomatic diabetic patients. Diabetes Care. 2004; 27(11):2736-8. DOI: 10.2337/diacare.27.11.2736. View

2.
van den Brom C, Huisman M, Vlasblom R, Boontje N, Duijst S, Lubberink M . Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol. 2009; 8:39. PMC: 2722582. DOI: 10.1186/1475-2840-8-39. View

3.
Movahed M, Milne N . Presence of biventricular dysfunction in patients with type II diabetes mellitus. Congest Heart Fail. 2007; 13(2):78-80. DOI: 10.1111/j.1527-5299.2007.888138.x. View

4.
Rytter L, Troelsen S, Beck-Nielsen H . Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 1985; 8(3):230-4. DOI: 10.2337/diacare.8.3.230. View

5.
Golfman L, Wilson C, Sharma S, Burgmaier M, Young M, Guthrie P . Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab. 2005; 289(2):E328-36. DOI: 10.1152/ajpendo.00055.2005. View